Allogene Therapeutics (ALLO) Treasury Shares (2018)

Allogene Therapeutics has reported Treasury Shares for 8 years, with the latest figure at $16.5 million in Q4 2025.

• Quarterly Treasury Shares rose 23.86% year-over-year to $16.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $16.5 million (up 23.86% YoY) and the FY2025 annual result came in at $16.5 million, up 23.86% from the prior year.
• Treasury Shares fell to $16.5 million in Q4 2025 per ALLO's latest filing, from $16.6 million in the prior quarter.
• Over five years, Treasury Shares peaked at $16.6 million in Q3 2025 and troughed at $3.1 million in Q1 2021.
• A 5-year average of $9.2 million and a median of $9.2 million in 2022 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2023 and 2025: Treasury Shares jumped 146.5% in 2023, then tumbled 65.39% in 2025.
• Over 5 years, Treasury Shares stood at $4.3 million in 2021, then increased by 28.92% to $5.5 million in 2022, then jumped by 121.73% to $12.2 million in 2023, then climbed by 9.55% to $13.3 million in 2024, then climbed by 23.86% to $16.5 million in 2025.
• According to Business Quant data, Treasury Shares over the past three periods registered $16.5 million, $16.6 million, and $4.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.